Using RNAi to Target PRDMs in Cancer

Time: 2:00 pm
day: Day One

Details:

  • ARIZ is developing siRNA candidates targeting upregulated PRDM isoforms in cancer
  • PRDM2 isoform RIZ2 is highly overexpressed in lung cancer
  • Success in extrahepatic siRNA delivery using a targeted calcium phosphate nanoparticle delivery system

Speakers: